Invention Grant
- Patent Title: Tissue culture system for production of hepatitis C virus
- Patent Title (中): 组织培养系统用于生产丙型肝炎病毒
-
Application No.: US12310309Application Date: 2007-08-22
-
Publication No.: US08481050B2Publication Date: 2013-07-09
- Inventor: Qui-Lim Choo , Jang Han , Michael Houghton , Taewoo Kwon , Hyun Chul Song , Yifei Zhu
- Applicant: Qui-Lim Choo , Jang Han , Michael Houghton , Taewoo Kwon , Hyun Chul Song , Yifei Zhu
- Applicant Address: US CA Emeryville
- Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee Address: US CA Emeryville
- Agent Roberta L. Robins; Kenneth M. Goldman
- International Application: PCT/US2007/018591 WO 20070822
- International Announcement: WO2008/024413 WO 20080228
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A61K50/00

Abstract:
A tissue culture system for production of infectious hepatitis C virus is described. In particular, the invention provides recombinant monocistronic and bicistronic genomic constructs for production of virus, including constructs for production of wild-type HCV type 2a strain JFH1 and constructs for production of chimeric viruses comprising HCV proteins from strain JFH1 and a second HCV isolate. Constructs of the invention also include a reporter gene to facilitate measurement of RNA replication and viral infectivity in cultures. The cell culture system may also include various factors that improve viral replication or infectivity. In addition, a neutralization assay using HCV grown in cell culture is described.
Public/Granted literature
- US20100227311A1 TISSUE CULTURE SYSTEM FOR PRODUCTION OF HEPATITIS C VIRUS Public/Granted day:2010-09-09
Information query